Transport pathways in the malaria-infected erythrocyte: characterization and their use as potential targets for chemotherapy.
The intraerythrocytic malarial parasite is involved in an extremely intensive anabolic activity while it resides in its metabolically quiescent host cell. The necessary fast uptake of nutrients and the discharge of waste product, are guaranteed by parasite-induced alterations of the constitutive transporters of the host cell and the production of new parallel pathways. The membrane of the host cell thus becomes permeable to phospholipids, purine bases and nucleosides, small non-electrolytes, anions and cations. When the new pathways are quantitatively unimportant, classical inhibitors of native transporters can be used to inhibit parasite growth. Several compounds were found to effectively inhibit the new pathways and consequently, parasite growth. The pathways have also been used to introduce cytotoxic agents. The parasitophorous membrane consists of channels which are highly permeable to small solutes and display no ion selectivity. Transport of some cations and anions across the parasite membrane is rapid and insensitive to classical inhibitors, and in some cases it is mediated by specific antiporters which respond to their respective inhibitors. Macromolecules have been shown to reach the parasitophorous space through a duct contiguous with the host cell membrane, and subsequently to be endocytosed at the parasite membrane. The simultaneous presence of the parasitophorous membrane channels and the duct, however, is incompatible with experimental evidences. No specific inhibitors were found as yet that would efficiently inhibit transport through the channels or the duct.
Ginsburg
H
H
Department of Biological Chemistry, Hebrew University of Jerusalem, Israel.
D000818:Animals; D002463:Cell Membrane Permeability; D004910:Erythrocyte Membrane / Q000737:chemistry / Q000378:metabolism / Q000469:parasitology; D006790:Host-Parasite Interactions; D008288:Malaria / Q000188:drug therapy*; D010743:Phospholipids / Q000378:metabolism / Q000493:pharmacokinetics; D010963:Plasmodium falciparum / Q000472:pathogenicity*
D010743:Phospholipids